Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · IEX Real-Time Price · USD
132.54
-0.69 (-0.52%)
At close: Apr 18, 2024, 4:00 PM
131.80
-0.74 (-0.56%)
After-hours: Apr 18, 2024, 7:24 PM EDT
Neurocrine Biosciences Market Cap
Neurocrine Biosciences has a market cap or net worth of $13.19 billion as of April 18, 2024. Its market cap has increased by 32.29% in one year.
Market Cap
13.19B
Enterprise Value
12.59B
1-Year Change
32.29%
Ranking
Category
Stock Price
$132.54
Market Cap Chart
Since December 1, 1998, Neurocrine Biosciences's market cap has increased from $124.10M to $13.19B, an increase of 10,527.50%. That is a compound annual growth rate of 20.17%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 17, 2024 | 13.26B | 0.18% |
Apr 16, 2024 | 13.23B | 0.95% |
Apr 15, 2024 | 13.11B | -2.17% |
Apr 12, 2024 | 13.40B | -0.93% |
Apr 11, 2024 | 13.53B | -1.56% |
Apr 10, 2024 | 13.74B | -0.61% |
Apr 9, 2024 | 13.83B | -0.36% |
Apr 8, 2024 | 13.88B | 0.37% |
Apr 5, 2024 | 13.82B | 0.95% |
Apr 4, 2024 | 13.69B | 0.01% |
Apr 3, 2024 | 13.69B | -0.11% |
Apr 2, 2024 | 13.71B | -2.57% |
Apr 1, 2024 | 14.07B | 2.51% |
Mar 28, 2024 | 13.72B | 0.07% |
Mar 27, 2024 | 13.72B | -2.36% |
Mar 26, 2024 | 14.05B | 0.65% |
Mar 25, 2024 | 13.96B | -0.83% |
Mar 22, 2024 | 14.07B | -1.61% |
Mar 21, 2024 | 14.30B | 2.20% |
Mar 20, 2024 | 14.00B | -0.16% |
Mar 19, 2024 | 14.02B | 1.03% |
Mar 18, 2024 | 13.88B | 0.24% |
Mar 15, 2024 | 13.84B | -0.04% |
Mar 14, 2024 | 13.85B | -1.86% |
Mar 13, 2024 | 14.11B | 2.95% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Skye Bioscience | 16.73B |
Walgreens Boots Alliance | 15.12B |
BeiGene | 14.98B |
Teva Pharmaceutical | 14.71B |
Quest Diagnostics | 14.04B |
Viatris | 13.27B |
Royalty Pharma | 12.46B |
ShockWave Medical | 12.26B |